| Milad Ishak Shaker, MD | |
|
308 Bessemer Rd, Suite 100, Mount Pleasant, PA 15666-9134 | |
| (724) 542-4296 | |
| (724) 542-4298 |
| Full Name | Milad Ishak Shaker |
|---|---|
| Gender | Male |
| Speciality | Family Medicine |
| Location | 308 Bessemer Rd, Mount Pleasant, Pennsylvania |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114184124 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | MD437512 (Pennsylvania) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Milad Ishak Shaker, MD 308 Bessemer Rd, Ste 100, Mount Pleasant, PA 15666-9134 Ph: (724) 542-4296 | Milad Ishak Shaker, MD 308 Bessemer Rd, Suite 100, Mount Pleasant, PA 15666-9134 Ph: (724) 542-4296 |
News Archive
Pfizer is pleased to announce that the MHRA has approved the reclassification of the well-established proton pump inhibitor (PPI) Nexium Control (esomeprazole), making it available for consumers to purchase it without a prescription.
Durata Therapeutics today announced results from its QT study of the company's lead product candidate, dalbavancin. Dalbavancin is currently under investigation in two ongoing, global, Phase 3 clinical trials for the treatment of acute bacterial skin and skin structure infections (ABSSSI).
Clinuvel Pharmaceuticals Limited, a global biopharmaceutical company with unique expertise on the interaction of light and human skin, today announced positive results of its first US Phase II study of the novel photoprotective drug afamelanotide, known as SCENESSE.
A commonly used anti-anginal drug reduces chest pain in patients with type 2 diabetes and appears to have a more pronounced effect in those with poorer glucose control, according to research presented today at the American College of Cardiology's 62nd Annual Scientific Session.
Treating acute lymphocytic leukemia (ALL) can bring many challenges, particularly in the adult population. To optimally manage this disease in adult patients, healthcare professionals must understand and identify characteristics of high-risk disease, utilize best strategies for preventing central nervous system relapse, and recognize the important role of post-remission hematopoietic stem cell transplantation in ALL therapy.
› Verified 2 days ago
Jarrett J Bender, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 525 W Main St, Mount Pleasant, PA 15666 Phone: 724-547-4536 Fax: 724-547-3799 | |
Paul James Myers, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 508 S Church St, Mount Pleasant, PA 15666 Phone: 724-547-1636 Fax: 724-547-1762 | |
Sara Nakhal, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 20 E Main St, Mount Pleasant, PA 15666 Phone: 724-547-3576 | |
Dr. Albert Timothy Saloom, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 6533 Route 819, Mount Pleasant, PA 15666 Phone: 724-547-5501 Fax: 724-547-5510 |